WallStSmart
CNTX

Context Therapeutics Inc

NASDAQ: CNTX · HEALTHCARE · BIOTECHNOLOGY

$2.34
-6.77% today

Updated 2026-04-29

Market cap
$207.65M
P/E ratio
P/S ratio
EPS (TTM)
$-0.38
Dividend yield
52W range
$0 – $4
Volume
0.9M

Context Therapeutics Inc (CNTX) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
-10.3%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
-366.7%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-10.5%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-20.1%
2026-03-25
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-25$-0.14-36.6%$3.18$2.54-20.1%
2025-11-06$-0.10-11.1%$1.13$1.12-0.9%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2025-12-31$-0.10$-0.14-36.6%
2025-09-30$-0.09$-0.10-11.1%
2025-06-30$-0.06$-0.09-52.0%
2025-03-31$-0.12$-0.05+58.3%
2024-12-31$-0.06$-0.03+47.1%
2024-09-30$-0.05$-0.22-340.0%
2024-06-30$-0.07$-0.04+40.0%
2024-03-31$-0.44$-0.23+47.7%
2023-12-31$-0.35$-0.42-20.0%$18952.00
2023-09-30$-0.37$-0.37+0.0%
2023-06-30$-0.20$-0.31-55.0%
2023-03-31$-0.34$-0.40-17.6%

Frequently asked questions

Has Context Therapeutics Inc beaten earnings estimates?
Context Therapeutics Inc has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of -10.3% over the last 4 quarters.
How does CNTX stock react to earnings?
CNTX stock has moved an average of -10.5% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.